Sacubitril/Valsartan
| Post Date: | Jan 11,2022 |
| Expiry Date: | Jul 10,2022 |
| Detailed Description: |
Cas No. :936623-90-4 Quantity: 1000Kilograms Specs:99% Price:2500 USD Metric Tons Payment Method: l/c,t/t LCZ696 CAS NO: 936623-90-4 Name: Entresto; L-Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, compd. with α-ethyl (αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl[1,1′-biphenyl]-4-pentanoate, sodium salt, hydrate (2:2:6:5); trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3-methyl-2-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4-ylmethyl}amino)butyrate] hemipentahydrate; trisodium 3-((1S,3R)-1-(biphenyl-4-ylmethyl)-3-(ethoxycarbonyl)butylcarbamoyl)propionate (S)-3-methyl-2-(pentanoyl-(2-(tetrazol-1-at-5-yl)biphenyl-4′-ylmethyl)amino)butyrate hemipentahydrate;Sacubitril/Valsartan MF: C48H55N6Na3O8 MW: 912.95500 Notice: If the compound involved in patent protection, do not use for commercial purposes, and only for the purpose of analysis and research experiments. If it’s sold to countries which constitute patent infringement, All the risks corresponding are unrelated to our company |
| CAS Registry Number: |
936623-90-4 |
| Synonyms: | ;Entresto;L-Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, compd. with α-ethyl (αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl[1,1′-biphenyl]-4-pentanoate, sodium salt, hydrate (2:2:6:5); trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3-methyl-2-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4-ylmethyl}amino)butyrate] hemipentahydrate;trisodium 3-((1S,3R)-1-(biphenyl-4-ylmethyl)-3-(ethoxycarbonyl)butylcarbamoyl)propionate (S)-3-methyl-2-(pentanoyl-(2-(tetrazol-1-at-5-yl)biphenyl-4′-ylmethyl)amino)butyrate hemipentahydrate;LCZ 696;Sacubitril mixture with Valsartan;Valsartan/Sacubitril 3Na-2.5 H2O;Valsartan-Sacubitril sodium;sacubitril/valsartan; |
| Molecular Formula: | C48H55N6Na3O8 |
| Molecular Weight: | 912.95500 |
| Molecular Structure: | 
|